Literature DB >> 30964836

Brain Death Enhances Activation of the Innate Immune System and Leads to Reduced Renal Metabolic Gene Expression.

Laura J Zitur1, Peter J Chlebeck1, Scott K Odorico1, Juan S Danobeitia1, Tiffany J Zens1, Cees Van Kooten2, Michael Eerhart1, Jose A Reyes1, Megan L Springer1, Jennifer M Coonen3, Kevin G Brunner3, Saverio V Capuano3, Anthony M D'Alessandro1, Luis A Fernandez1.   

Abstract

BACKGROUND: Brain death (BD)-associated inflammation has been implicated in decreased kidney allograft function and survival, but the underlying mechanisms have not been well distinguished from the conditions of critical care itself. We have developed a clinically translatable model to separate and investigate strategies to improve donor management and critical care.
METHODS: Brain-dead (n = 12) and sham (n = 5) rhesus macaques were maintained for 20 hours under intensive care unit-level conditions. Samples were collected for immunophenotyping, analysis of plasma proteins, coagulation studies, and gene analysis for changes in immune and metabolic profile with comparison to naive samples (n = 10).
RESULTS: We observed an increase in circulating leukocytes and cytokines, activation of complement and coagulation pathways, and upregulation of genes associated with inflammation in both brain-dead and sham subjects relative to naïve controls. Sham demonstrated an intermediate phenotype of inflammation compared to BD. Analysis of gene expression in kidneys from BD kidneys revealed a similar upregulation of inflammatory profile in both BD and sham subjects, but BD presented a distinct reduction in metabolic and respiratory processes compared to sham and naïve kidneys.
CONCLUSION: BD is associated with activation of specific pathways of the innate immune system and changes to metabolic gene expression in renal tissue itself; however, sham donors presented an intermediate inflammatory response attributable to the critical care environment. The early onset and penetrating impact of this inflammatory response underscores the need for early intervention to prevent perioperative tissue injury to transplantable organs.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30964836      PMCID: PMC6713605          DOI: 10.1097/TP.0000000000002744

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  33 in total

1.  Influence of brain death on cytokine release in organ donors and renal transplants.

Authors:  M Stangl; T Zerkaulen; J Theodorakis; W Illner; H Schneeberger; W Land; E Faist
Journal:  Transplant Proc       Date:  2001 Feb-Mar       Impact factor: 1.066

Review 2.  Activation of proinflammatory genes in somatic organs as a consequence of brain death.

Authors:  J Pratschke; M J Wilhelm; M Kusaka; W W Hancock; N L Tilney
Journal:  Transplant Proc       Date:  1999 Feb-Mar       Impact factor: 1.066

Review 3.  Brain death and its influence on donor organ quality and outcome after transplantation.

Authors:  J Pratschke; M J Wilhelm; M Kusaka; M Basker; D K Cooper; W W Hancock; N L Tilney
Journal:  Transplantation       Date:  1999-02-15       Impact factor: 4.939

4.  Accelerated rejection of renal allografts from brain-dead donors.

Authors:  J Pratschke; M J Wilhelm; M Kusaka; F Beato; E L Milford; W W Hancock; N L Tilney
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

5.  Maladaptive role of IL-6 in ischemic acute renal failure.

Authors:  Mariusz L Kielar; Reji John; Michael Bennett; James A Richardson; John M Shelton; Liying Chen; D Rohan Jeyarajah; Xin J Zhou; Hui Zhou; Brett Chiquett; Glenn T Nagami; Christopher Y Lu
Journal:  J Am Soc Nephrol       Date:  2005-09-28       Impact factor: 10.121

6.  Effect of brain death on gene expression and tissue activation in human donor kidneys.

Authors:  Willemijn N Nijboer; Theo A Schuurs; Joost A B van der Hoeven; Susan Fekken; Janneke Wiersema-Buist; Henri G D Leuvenink; Sijbrand Hofker; Jaap J Homan van der Heide; Willem J van Son; Rutger J Ploeg
Journal:  Transplantation       Date:  2004-10-15       Impact factor: 4.939

7.  Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion.

Authors:  Nimesh S A Patel; Prabal K Chatterjee; Rosanna Di Paola; Emanuela Mazzon; Domenico Britti; Angelina De Sarro; Salvatore Cuzzocrea; Christoph Thiemermann
Journal:  J Pharmacol Exp Ther       Date:  2004-11-30       Impact factor: 4.030

8.  Cadaveric versus living-donor livers: differences in inflammatory markers after transplantation.

Authors:  Wayel Jassem; Dicken D H Koo; Lucia Cerundolo; Mohamed Rela; Nigel D Heaton; Susan V Fuggle
Journal:  Transplantation       Date:  2003-12-15       Impact factor: 4.939

9.  Cytokine upregulation of surface antigens correlates to the priming of the neutrophil oxidative burst response.

Authors:  S Wittmann; G Rothe; G Schmitz; D Fröhlich
Journal:  Cytometry A       Date:  2004-01       Impact factor: 4.355

10.  Raised parenchymal interleukin-6 levels correlate with improved outcome after traumatic brain injury.

Authors:  Craig D Winter; Ashley K Pringle; Geraldine F Clough; Martin K Church
Journal:  Brain       Date:  2003-11-25       Impact factor: 13.501

View more
  3 in total

1.  Caspase-1 Inhibitor Reduces Pyroptosis Induced by Brain Death in Kidney.

Authors:  Weifeng Liu; Dongjing Yang; Jihua Shi; Peihao Wen; Jiakai Zhang; Zhihui Wang; Bowen Hu; Xiaoyi Shi; Shengli Cao; Wenzhi Guo; Shuijun Zhang
Journal:  Front Surg       Date:  2021-11-26

2.  Serum Antibody Binding and Cytotoxicity to Pig Cells in Chinese Subjects: Relevance to Clinical Renal Xenotransplantation.

Authors:  Tao Li; Hao Feng; Jiaxiang Du; Qiangbing Xia; David K C Cooper; Hongtao Jiang; Songzhe He; Dengke Pan; Gang Chen; Yi Wang
Journal:  Front Immunol       Date:  2022-03-10       Impact factor: 7.561

Review 3.  Kidney Perfusion as an Organ Quality Assessment Tool-Are We Counting Our Chickens Before They Have Hatched?

Authors:  Julie De Beule; Ina Jochmans
Journal:  J Clin Med       Date:  2020-03-23       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.